- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: buparlisib (BKM120)
Total 104 results
-
Novartis PharmaceuticalsCompletedRenal ImpairmentCzechia, Germany, Romania, Bulgaria
-
Won KimNovartisTerminated
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
Dana-Farber Cancer InstituteCompleted
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular LymphomaUnited States, Belgium, Germany, France, Italy, Korea, Republic of, Spain, Turkey
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedLymphoma | Primary Central Nervous System Lymphoma | Recurrent/Refractory Secondary Central Nervous System LymphomaUnited States
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Patrick Y. Wen, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Anne ChangNovartis PharmaceuticalsTerminatedCarcinoma, Basal Cell | Skin Neoplasms | Basal Cell Nevus Syndrome | Recurrent Skin CancerUnited States
-
Centre Leon BerardNational Cancer Institute, France; Fondation ARCCompletedHead and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent DiseaseFrance
-
Fondazione MichelangeloCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
University of OxfordNovartis; Cancer Research UKCompleted
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
Novartis PharmaceuticalsTerminatedHead and Neck Squamous Cell CarcinomaGermany, United Kingdom, United States, Spain, Italy, Canada, Poland, Russian Federation, Switzerland, Thailand, Korea, Republic of, Hungary, Ireland, Australia, Taiwan, France, India, Japan
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedHypopharyngeal Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Early Invasive Cervical Squamous Cell Carcinoma | Cancer of Nasopharynx | Carcinoma of LarynxUnited States
-
Emory UniversityNovartis PharmaceuticalsCompletedLung Cancer | Solid TumorsUnited States
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
SCRI Development Innovations, LLCNovartisCompletedGlioblastoma MultiformeUnited States
-
US Oncology ResearchNovartis PharmaceuticalsCompletedBreast Cancer | Metastatic Breast Cancer | Brain MetastasesUnited States
-
SCRI Development Innovations, LLCNovartisCompletedNon Small Cell Lung CancerUnited States
-
Canadian Cancer Trials GroupNovartisCompletedChronic Lymphocytic LeukemiaCanada
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
University Hospital TuebingenUniversity Hospital DresdenUnknownMalignant Melanoma | MetastasesGermany
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Novartis PharmaceuticalsCompletedLymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
ARCAGY/ GINECO GROUPCompleted
-
Novartis PharmaceuticalsCompletedPI3K Pathway Activated TumorsUnited States
-
Novartis PharmaceuticalsNovartisWithdrawnTreatment for Metastatic or Locally Advanced Cervical CancerBrazil
-
Prince of Songkla UniversityTerminatedEsophageal CancerThailand
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Hospices Civils de LyonUnknown
-
Sofia Perea, Director Clinical Trials Unit.NovartisCompleted
-
Patrick Joseph Loehrer Sr.Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Breast Cancer, Advanced Carcinomas With Squamous Cell HistologyChina
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentGermany, Russian Federation, Bulgaria
-
SOLTI Breast Cancer Research GroupDana-Farber Cancer Institute; Novartis Pharmaceuticals; Stand Up To CancerCompletedBreast CancerUnited States, Spain
-
Massachusetts General HospitalNovartis PharmaceuticalsWithdrawnBreast Cancer | Colorectal Cancer | Lung Cancer | Cholangiocarcinoma | Solid Tumors
-
Yonsei UniversityUnknownHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
University Hospital, EssenNovartis Pharmaceuticals; iOMEDICO AGCompleted
-
Andrew J. Armstrong, MDNovartis PharmaceuticalsTerminatedProstate Cancer | Metastatic (Spread to Other Areas of the Body)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States